MoneyWorks4Me

Lactose India - Quaterly Results

14 Feb 2026 Evaluate
The sales for the December 2025 quarter moved up 28.02% to Rs. 367.67 millions as compared to Rs. 287.19 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 140.00% to Rs. 5.28  millions from Rs. 2.20 millions in the previous quarter.Operating profit for the quarter ended December 2025 rose to 36.98 millions as compared to 35.26 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 367.67 287.19 28.02 1175.24 886.29 32.60 1163.99 1138.90 2.20
Other Income 6.34 5.62 12.81 14.21 10.83 31.21 14.54 11.25 29.24
PBIDT 36.98 35.26 4.88 142.09 146.31 -2.88 184.12 201.36 -8.56
Interest 13.94 16.37 -14.84 36.56 42.65 -14.28 61.03 52.53 16.18
PBDT 23.04 18.89 21.97 105.53 103.66 1.80 123.09 148.83 -17.29
Depreciation 14.26 13.54 5.32 42.42 39.97 6.13 53.91 52.19 3.30
PBT 8.78 5.35 64.11 63.11 63.69 -0.91 69.18 96.64 -28.41
TAX 3.50 3.15 11.11 21.26 18.48 15.04 17.54 28.76 -39.01
Deferred Tax 2.03 1.65 23.03 10.72 7.24 48.07 4.38 13.09 -66.54
PAT 5.28 2.20 140.00 41.85 45.21 -7.43 51.64 67.88 -23.92
Equity 125.89 125.89 0.00 125.89 125.89 0.00 125.89 125.89 0.00
PBIDTM(%) 10.06 12.28 -18.08 12.09 16.51 -26.76 15.82 17.68 -10.53
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..